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Although most causes of death and morbidity in premature infants are related to immune
maladaptation, the premature immune system remains poorly understood. We provide a
comprehensive single-cell depiction of the neonatal immune system at birth across the
spectrum of viable gestational age (GA), ranging from 25 weeks to term. A mass
cytometry immunoassay interrogated all major immune cell subsets, including signaling
activity and responsiveness to stimulation. An elastic net model described the relationship
between GA and immunome (R=0.85, p=8.75e-14), and unsupervised clustering
highlighted previously unrecognized GA-dependent immune dynamics, including
decreasing basal MAP-kinase/NFkB signaling in antigen presenting cells; increasing
responsiveness of cytotoxic lymphocytes to interferon-a; and decreasing frequency of
regulatory and invariant T cells, including NKT-like cells and CD8+CD161+ T cells.
Knowledge gained from the analysis of the neonatal immune landscape across GA
provides a mechanistic framework to understand the unique susceptibility of preterm
infants to both hyper-inflammatory diseases and infections.
Keywords: Neonatal immunology, neonatal T cells, neonatal antigen presenting cells, neonatal NK cells, neonatal
cytotoxic cells, prematurity
INTRODUCTION
Prematurity is one of the most pressing clinical imperatives of our day: it affects approximately 10-
15% of pregnancies and kills more than one million babies every year, making it the leading cause of
death in children under five (1). Furthermore, survivors often suffer from devastating short- and
long-term morbidities, and the earlier an infant is born, the greater their risk of adverse outcome
(2, 3). Sepsis, bronchopulmonary dysplasia (BPD, a cause of life-pulmonary insufficiency),
necrotizing enterocolitis [NEC, a devastating inflammatory disease of the gut with a 30-40%
mortality rate (4)], retinopathy of prematurity [ROP, one of the top three causes of blindness in
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children in the developed world (5)], and neurodevelopmental
impairment afflict well over half of infants born extremely
preterm at less than 28 weeks gestational age (GA) (2). Each of
these diseases shares immune maladaptation as a common
pathophysiology: sepsis is associated with immune compromise,
while BPD, NEC, ROP, and certain causes of neurodevelopmental
impairment have been linked to hyper-inflammatory states (6–10).
As such, the health and well-being of premature infants can be
greatly improved with a better understanding of the neonatal
immune system.
It has been almost 70 years since Sir Peter Medawar first began
to uncover the unique complexities of the neonatal immune system
(11). Since then, decades of research have provided insight into the
multifaceted derangements in both the innate and adaptive immune
system in newborns (12). Neonates, particularly those born
prematurely, have increased susceptibility to a variety of
infections, including pathogens that cause mild or no illness in
adults and older children, such as group B streptococcus,
Staphylococcus epidermidis, respiratory syncytial virus, herpes
simplex virus, cytomegalovirus, and adenovirus (12–14). Preterm
neonates also demonstrate decreased antibody titers in response to
vaccines and other antigenic stimuli (15). Especially in the
premature neonate, evidence suggests that regulatory immune
phenomena essential for feto-maternal immune tolerance persist
into post-natal life, contributing to the particular vulnerability of
this population to impaired immune responses to antigen (15–17).
Despite the attenuation of some adaptive immune responses, the
premature infant is also susceptible to exaggerated inflammatory
reactions, primarily in the innate system, that contribute to the main
inflammatory morbidities of prematurity, including BPD, ROP,
NEC, and certain neurologic injury. Exposure to oxygen and
mechanical ventilation lead to inflammatory cascades that
underlie the pathogenesis of such diseases as retinopathy of
prematurity and bronchopulmonary dysplasia (18). Similarly,
hyper-inflammatory immune responses to enteric bacteria are
thought to contribute to NEC, a serious inflammatory disease of
the gut with a high mortality rate (19). Epidemiologic evidence and
animal studies also implicate fetal and neonatal inflammation in
long-term neurodevelopmental impairments common in
prematurity (10, 20). Although these morbidities develop over
time, studies suggest that the immune status at the time of birth
may be a key indicator for which infants aremost vulnerable; several
authors have demonstrated that cytokine levels in umbilical cord
blood correlate with neurodevelopmental outcomes (21–24), ROP
(25), BPD (26, 27), periventricular leukomalacia (a major cause of
adverse neurodevelopmental outcomes) (24), and NEC (28).
Despite the profound impact of the imbalance of innate
immune hyperinflammation and antigen hypo-responsiveness
on the short and long-term health of these vulnerable patients,
the underlying biological mechanisms remain poorly
understood. Most prior reports on the relationship between
GA and the neonatal immune system have been constrained to
the study of only a small subset of immune cells or to a limited
examination of signaling responses and functional capacity, and
many studies have limited their analysis to examining arbitrary
GA categories rather than studying the immune system along a
continuum. The recent rise of systems immunology opens the
door for the creation of a comprehensive map of the immune
landscape at birth, which in turn can lay the groundwork for a
better understanding of the immunologic derangements that
predispose preterm infants to excess morbidity and mortality.
Olin et al. (29) recently reported an elegant survey of the neonatal
immune system using a systems immunology approach (mass
cytometry and pooled proteomics and transcriptomics) to
identify differences between preterm and term infants, although
the assays used did not provide information on immune cell
signaling or responsiveness, the analysis was based on
categorization of patients into broad “term” and “preterm” cohorts,
and clinical confounders such as perinatal infection and antenatal
steroid administration were not addressed.
We employ a high-dimensional mass cytometry immunoassay
to functionally interrogate on a single-cell level all major innate and
adaptive immune cells, including their baseline signaling state and
capacity to respond to inflammatory stimuli, in umbilical cord
blood of premature and healthy term neonates examined across a
spectrum of viable GA (25 weeks to term), forgoing arbitrary
categorization of prematurity into gestational classes. The primary
goal of the study is to characterize comprehensively the progression
of neonatal immune cell census and signaling behavior across the
GA continuum. This survey is a necessary keystone for the
formation of hypotheses explaining the disproportionate
predisposition of the earliest preterm infants to infection and the
inflammatory morbidities of prematurity.
MATERIALS AND METHODS
Study Design and Sample Collection
The study was conducted at the Lucile Packard Children’s Hospital
(Stanford, CA, USA). The study was approved by the Institutional
Review Board, and all parental participants signed an informed
consent. Pregnant women were considered eligible for the study if
they were capable of providing informed consent. Exclusion criteria
were major fetal congenital anomalies, maternal chronic
inflammatory diseases or autoimmunity, active infection, and
monochorionic multiple pregnancy. If a woman developed
clinical signs of chorioamnionitis at any point during her labor,
she was excluded from the study. Placental pathology was reviewed
retrospectively for the presence of subclinical chorioamnionitis.
Sample Processing and Ex Vivo
Whole-Blood Immunoassay
Umbilical cord blood from the umbilical vein was collected at the
time of delivery into heparinized vacutainers. Whole cord blood
was processed within 60 minutes after blood draw. Individual
Abbreviations: GA, gestational age; BPD, bronchopulmonary dysplasia; cMC,
classical monocyte; DC, dendritic cell; EN, elastic net; IFNa, interferon alpha;
intMC, intermediate monocyte; MAIT, mucosal associated invariant T cell; LPS,
lipopolysaccharide; ncMC, nonclassical monocyte; NEC, necrotizing enterocolitis;
NK, natural killer; ROP, retinopathy of prematurity; p, phospho-; pDC,
plasmacytoid dendritic cell; PVL, periventricular leukomalacia; TCM, T central
memory cell; TEM, T effector memory cell; TEMRA, effector memory T cells re-
expressing CD45RA; Treg, regulatory T cell; TLR-4, Toll like receptor 4.
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aliquots were stimulated for 15 min at 37°C with LPS (1 µg/mL,
InvivoGen, San Diego, CA), IFN-a (100 ng/mL, PBL Assay
Science, Piscataway, NJ), a cocktail of IL-2, IL-4, and IL-6
(each 100 ng/mL, R&D Systems), or left unstimulated. Samples
were processed using a standardized protocol for fixation with
proteomic stabilizer (SMART TUBE, Inc., San Carlos, CA) and
stored at -80°C until further processing.
Mass Cytometry
Antibody Staining and Mass Cytometry
The mass cytometry antibody panel included 38 antibodies, 27
that were used for cell typing and 11 antibodies for the functional
characterization of immune cell responses (Supplemental Table
S1). Antibodies were either obtained preconjugated (Fluidigm,
Inc.) or were purchased as purified, carrier free (no BSA, gelatin)
versions, which were then conjugated in-house with trivalent
metal isotopes utilizing the MaxPAR antibody conjugation kit
(Fluidigm, Inc.). After incubation with Fc block (Biolegend),
pooled barcoded cells were stained with surface antibodies, then
permeabilized with methanol and stained with intracellular
antibodies. All antibodies used in the analysis were titrated and
validated on samples that were processed identically to the
samples used in the study. Barcoded and antibody-stained cells
were analyzed on the mass cytometer (Helios CyTOF, Fluidigm
Inc., South San Francisco, CA).
The mass cytometry data was normalized using Normalizer
v0.1 MATLAB Compiler Runtime (MathWorks) (30). Files were
then de-barcoded with a single-cell MATLAB debarcoding tool
(31). Manual gating was performed using CellEngine (https://
immuneatlas.org/#/) (Primity Bio, Fremont, CA), according to
the gating strategy in Supplemental Figure S1, identifying 34
manually gated cell types.
Cell Frequency, Basal Intracellular Signaling and
Intracellular Signaling Responses
The data from each sample were analyzed for basal intracellular
signaling tone and intracellular signaling responses in thirty-four
adaptive and innate immune cell subsets. Cell frequencies were
expressed as a percentage derived from singlet live mononuclear
cells (DNA+cPARP−CD235−CD61−CD66−), except for granulocyte
frequencies, which were expressed as percentage of singlet live
leukocytes (DNA+cPARP−CD235−CD61−). Endogenous
intracellular signaling activities at the basal (unstimulated) level
were quantified per single cell for phospho-(p)STAT1, pSTAT3,
pSTAT5, pSTAT6, pCREB, pMAPKAPK2, pERK1/2, pS6, pP38,
and pNFkB, and total IkB using an arcsinh transformed value
calculated from the median signal intensity [asinh(x/5)].
Intracellular signaling responses to stimulation were reported as
the difference in arcsinh transformed value of each signaling protein
between the stimulated and unstimulated conditions (arcsinh ratio
over basal signal). A knowledge-based penalization matrix was
applied to intracellular signaling response features in the mass
cytometry data based on mechanistic immunological knowledge,
as previously described (32, 33). Importantly, mechanistic priors
used in the penalization matrix are independent of immunological
knowledge related to neonatal immunology and GA.
Statistical Analysis
Pre-Processing
To remove features that are noisy or uninformative, we removed
those with lower variance than the 75th percentile among all
features available, and we removed all features with an absolute
median value lower than the median absolute value among all
features available.
Statistical Analysis
We used the R environment (http://www.r-project.org/) for
statistical analysis. For univariate analysis, we chose to apply a
continuous regression analysis (Spearman correlation) for each
feature relative to the GA at time of sampling. Shaded areas on
linear regression graphs represent 95% confidence intervals.
Multiple comparison corrections were performed using the
Benjamini-Hochberg procedure and reported as false discovery
rates (FDR). For the multivariate analysis, an Elastic Net (EN)
regularized regression model was trained on the pre-processed
dataset using the R package glmnet (version 4.0-2). In the EN
model, the immune features derived from mass cytometric
analysis were used to predict GA, which was treated as a
continuous variable. An underlying assumption of the EN
algorithm is statistical independence between all observations.
In this analysis, we assume independence as the samples come
from different subjects.
Cross Validation
In order to optimize the hyperparameters and assess the
reproducibility of the result fit, we used a leave-one-out cross
validation strategy. At each iteration, one sample is kept for
independent validation and its value is predicted as it is blinded
from the model training at this iteration. The reported results are
exclusively based on the blinded subject.
Clinical Confounder Analysis
We performed a confounder analysis on the values of the cross-
validated model by performing a least square linear regression
for all the main potential clinical confounders, one by one. For
each regression, the predictor is the GA, and the parameters are
the model predictions as well as one of the clinical confounders.
For each confounder, we evaluate the effects of the confounder
on and the predictions by optimizing the following difference:
jjg − b0 − b1xSG − b2xconfounderjj2 : We report for the p-value
associated with the F-statistic assessing whether the b
coefficients are different from zero, meaning that the variable
(prediction or confounder) has an effect. The EN model
predictions’ p-value measures if the EN model predictions
remain associated with GA for a regression in which we
control for each covariate. Similarly, the confounder p-value
measures if the covariate has an association with GA. N/As were
excluded from analysis.
Bootstrap Analysis
The EN approach provided a useful mathematical model to
demonstrate the progression of neonatal immune cells across
GA; however, the features selected by a single EN model are
Peterson et al. Neonatal Immune System Across GA
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susceptible to small variations in the data and are difficult to
reliably reproduce, which is particularly true in datasets such as
these with multiple highly correlated features (34, 35). This limits
their usefulness in studies like ours that are designed to explore
all immune features relevant to GA. To address these limitations,
a bootstrap procedure was applied that iterates the EN analysis
1,000 times on subsets of the data with replacement in order to
improve the likelihood of identifying all immune features
contributing to the GA-dependent progression of the neonatal
immune system and improving reproducibility of our results (see
Figure 3A for pictorial of process) (34, 35).
Correlation Network
The features are visualized using a correlation graph structure to
identify correlated feature populations using the R package
igraph (v1.2.5). Each immunologic feature is denoted by a
node. Edges were drawn between nodes with an absolute
Pearson correlation coefficient (|r|) >0.8. The graph is
visualized using the mds layout.
RESULTS
Study Participants
Forty-five infants were included in the study with birth GA
ranging from 25 weeks (w) 2 day (d) to 40w6d, including 25
infants born at term (≥37w) and 20 born preterm. Maternal
demographics and indications for delivery are shown in
Supplemental Tables S2, S3. Statistically significant differences
between women who delivered at term, those who delivered late
preterm (34w0d-36w6d) and those who delivered preterm
(<34w0d) include administration of steroids (betamethasone)
for fetal lung maturity to all mothers who delivered at <37 weeks
but to no mothers who delivered ≥37 weeks, greater proportion
of preeclampsia with severe features in the preterm group, and
highly variable duration of labor. No infants were born to
mothers with clinical chorioamnionitis, which was an
exclusion criterion for collection, or developed sepsis within
the 72 hours after birth. Placental pathology was available for
all preterm samples, all but two late preterm samples (both c-
section deliveries without labor or rupture of membranes), and
no term samples. Among those examined, one placenta at 30w6d
had mild histologic chorioamnionitis (stage 1, grade 1).
For each study participant, a neonatal blood sample was
collected from the umbilical vein at the time of delivery.
Figure 1 summarizes experimental and analytical pipelines. A
total of 1,071 immune cell features were analyzed in each sample
and visualized on a correlation network (Figure 2A). These
features included the frequencies of 34 innate and adaptive
immune cell subsets, the basal intracellular activity (i.e.
phosphorylation state) of 11 signaling proteins, and the
capacity of each cell subset and signaling molecule to respond
to a series of ligand-specific immune challenges [the bacterial
antigen lipopolysaccharide (LPS), the viral infection-associated
cytokine interferon (IFN)a, and a combination of interleukins
(IL)-2, IL-4, and IL-6, that have pleiotropic effects that include
influencing T cell differentiation and function]. A correlation
network of all studied immune features describes their
relationship with each other (Figure 2A).
High-Dimensional Modeling of Neonatal
Immune Cell Distribution and Signaling
Reveals a Gestational-Age Dependent
Immune System Progression From
Preterm to Term Gestation
Our goals for analysis of the high dimensional immunologic
dataset were to 1) confirm a relationship between GA and
immune profile by demonstrating that GA of an infant can be
predicted by his/her immune profile at birth, and 2) identify the
immune features that are most informative of (i.e. correlate with)
GA and understand their relationship with each other. An Elastic
Net (EN) model confirmed a strong association between GA and
immune profile (R=0.85, p=8.75e-14, Spearman correlation)
(Figure 2B). A total of 609 immune features informative of
GA were identified by iteratively applying the same ENmodel on
random subsets of data 1,000 times – a process known as
bootstrapping (Figure 3A and Supplemental Table S5). The
bootstrap technique addresses a common pitfall in the use of EN
for feature selection, which is that the features selected by a single
EN model are susceptible to small variations in the data and are
therefore difficult to reliably reproduce (34, 35).
In order to identify biologically relevant patterns in the data
and understand how these 609 features relate to each other, the
features were mapped onto the entire correlation network of all
identified immune features, and an agnostic clustering algorithm
(36) segregated the informative immune features into 23
communities (Supplemental Table S5), five of which
contained 95% of features and that were annotated based on
the underlying immunologic trends represented within them
(Figure 3B). A distinctive trend among informative features was
a progressive increase in ligand-specific responsiveness of
immune cell subsets as GA advances, illustrated by decreasing
non-specific basal signaling coupled with increasing amplitude of
ligand-specific responses (Figure 3C). A detailed examination of
the most significant (i.e. strongest Spearman correlation) of these
informative immune features within each community facilitates
the identification of potentially biologically important immune
differences during gestation that are revealed by the EN analysis.
The Relationship Between Immune Profile
and GA Remains Significant After
Addressing Clinical Confounders
The infants in our study were born secondary to a variety of
indications and to mothers with diverse medical backgrounds,
inevitably introducing possible confounding clinical variables. In
order to address these variables, we performed a post-hoc analysis
of the performance of the EN model with the one-by-one
addition of a confounding clinical variable. Importantly, the
model remained significant (p<0.0001) when accounting for
Peterson et al. Neonatal Immune System Across GA
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fetal sex, time between steroid administration and birth, duration
of rupture of membranes, duration of labor, maternal gestational
diabetes mellitus, maternal first trimester hemoglobin (Hgb)
A1c, preeclampsia, preeclampsia with severe features, and
maternal group B streptococcus status (Supplemental Table
S4). We chose to analyze time since steroid administration
rather than steroids as a categorical variable because all
preterm infants vs none of the term infants were exposed to
steroids, which would make the results uninterpretable. None of
the confounders were significant, including time since last
steroid administration (p=0.19). Although the number of
confounders is difficult to control for in this sample size,
A B
FIGURE 2 | Multivariate modeling analysis (EN) identifies a correlation between the comprehensive immune profile of an infant at birth and GA at birth. (A) A
correlation network of 1,071 immune features, representing the comprehensive immune profile at birth. Each node is an immune feature, consisting of the frequency
of an immune cell subset, its baseline signaling activity, or its signaling response to stimulation. Colors indicate the category of immune feature (frequency, basal
signaling, or evoked signaling response to IFNa, LPS, or IL). Lines are drawn between features with a correlation coefficient >0.8 (Pearson’s) (B) An Elastic Net
analysis created a model that could predict GA based on an infant’s comprehensive immune profile at birth, confirming the close relationship between GA and the
immune system.
FIGURE 1 | Functional profiling of the neonatal immune system across GA. Experimental and analytical workflow. 45 neonates ranging from 25w2d to 40w6d were
studied. Umbilical cord blood was obtained immediately after birth, and whole blood was either left unstimulated (control) or stimulated for 15 minutes with LPS,
IFNa, or a cocktail of interleukins (IL) (IL-2, IL-4, and IL-6). Immune cells were barcoded, stained with surface and intracellular antibodies, and analyzed with mass
cytometry. The assay produced five categories of immune features, providing information about cell frequency in 34 immune cell subsets, basal intracellular signaling
activity (i.e. phosphorylation state) of 11 intracellular signaling proteins in these cells, and cell type-specific signaling capacity in response to one of the three stimuli.
1,071 immune features were analyzed. Multivariate modeling using an Elastic Net method followed by a bootstrap procedure and unsupervised clustering of features
were applied to characterize the GA-dependent progression of immune cell features. Image credits: Figure 1 was created in part on BioRender.org.
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overall our analysis confirms that the changes we identified in the
immune profile are most likely due to GA rather than some
other confounder.
Advancing GA Is Associated With
Decreasing Frequency of Non-
Conventional Invariant and Regulatory
T Cell Subsets Coupled With Increasing
Frequency of Key Defensive Innate
Immune Cells
Community 3 contained information on the frequency of innate
and adaptive immune cells (Figure 4A). Within the innate
cellular compartment, the strongest correlations (Spearman)
with GA were increasing frequencies of granulocytes and
CD14+CD16- classical monocytes (cMCs) (Figures 4B, C),
which are front-line defenders that rapidly respond to injury
or infection (37, 38). In term infants, granulocytes comprised the
majority (58%) of immune cell subsets in cord blood, but at
earlier GA the proportion of granulocytes falls (average 24.5% of
live leukocytes in infants <30 weeks GA) and T lymphocytes
predominate (average 47.3% of live leukocytes in infants
<30 weeks, of which 64% are CD4+ T cells). In contrast, in the
adaptive compartment, the strongest correlations with GA were
decreasing frequencies of regulatory T cells (Treg) and CD161
+ T
cells, including the CD4+ and CD8+ subsets (Figures 4G–I). Treg
cells [and possibly fetal CD161+CD4+ T cells (39)] are immune-
regulatory cell subsets that can suppress antigen-specific T cell
inflammatory responses (40). CD8+CD161+ T cells are enriched
in mucosal associated invariant T (MAIT) cells that recognize
riboflavin metabolites presented by MHC-related 1 (MR1)
protein (although our assay did not include MR1 tetramers,
which are necessary for the definitive identification of MAITs)
(41–43). Also decreasing in frequency with GA were Natural
A
B C
FIGURE 3 | A bootstrap procedure with agnostic clustering reveals patterns in the immune system that change with advancing GA and suggests a progressive
increase in ligand-specific responsiveness of the immune system. (A) Analytical workflow for the bootstrap procedure used to identify immune correlates of GA.
Boxes with stars represent a data set, Xi, that can be used for EN training. We ran the EN model 1,000 times on random sub-samples of the data with replacement
and then tallied the number of times an individual feature was selected in one of the bootstrap iterations. (B) The 609 immune features identified by the bootstrap
procedure are highlighted on the correlation network of immune features and agnostically clustered into immunologically relevant communities, revealing patterns
in the immune system that vary with respect to GA. The 5 communities that contain 95% of the features are annotated based on the immunologic trends contained
within them (community 4 could be further sub-divided into 4a-c). Node size corresponds to frequency of occurrence of the feature in bootstrap iterations.
(C) Comparison of basal vs ligand-specific responses (i.e. after stimulation by LPS, IFNa, or IL) among informative immune features that correlate linearly
with GA [false discovery rate (FDR<0.1] shows that most (81.1%) basal signaling features decrease with advancing GA whereas most (76.9%) ligand-specific
features increase.
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Killer (NK) T cells, which are enriched in invariant NK (iNK) T
cells with a limited T cell receptor (TCR) repertoire specific for
lipid antigens presented by the non-classical MHC class I protein
CD1d (42, 44) (Figures 4D–F). Together these findings indicate
that at early GA the cellular composition of the neonatal immune
system is characterized by deficiencies in innate cells involved in the
acute response to infection or danger and a relative abundance of
suppressor T cells and a reliance on nonconventional T-cell
populations with restricted TCR repertoires directed to non-
peptide antigens.
Progressive Ligand-Specific
Responsiveness of Neonatal Immune Cell
Signaling With Advancing GA
In addition to GA-dependent progression of immune cell
distributions, several informative immune features represented
functional attributes, including basal signaling and responsiveness
of immune cells to stimuli meant to simulate gram negative
bacterial (LPS) or viral (IFNa) infection. Examination of the
functional attributes with the strongest statistical correlation
(Spearman) with GA in Communities 3 and 4c (Figure 5A)
revealed an intriguing evolution of the mitogen-activated protein
kinase (MAP-kinase)/NFkb pathway at baseline and in response
to LPS in antigen presenting cells, specifically dendritic cells (DC)s
and monocytic cell subsets [classical (c)MCs, intermediate (int)
MCs, and non-classical (nc)MCs]. Within this pathway, basal
pMAPKAPK2 signaling in antigen presenting cells demonstrated
the most prominent inverse relationship with GA (Figures 5B–D),
though other molecules in the same pathway, specifically pS6,
pP38, and pNFkB, followed a similar trajectory (Supplemental
Figure S3). In contrast to decreasing basal signaling, the
responsiveness of pMAPKAPK2 to the bacterial antigen LPS
increased with advancing GA in the same cell types, although
the relationship did not reach statistical significance in ncMCs
(Figures 5E–G). The MAP-kinase/NFkb pathway in antigen
presenting cells, which is down-stream of TLR4 activation by
LPS, is classically pro-inflammatory (45). Increased basal activity
of this pathway may speak to a tendency towards constitutively
active inflammatory reactions in prematurity, while decreased
responsiveness of pMAPKAPK2 to antigenic stimulation by LPS
may predispose infants to infection by certain bacterial pathogens.
Within Community 4b (Figure 6A), the features with the
strongest correlations (Spearman) were the responsiveness of
CD8+ and NK-cell lymphocyte subsets involved in cell-mediated
cytotoxicity to IFNa stimulation within the pSTAT3 pathway.
We observed an inverse relationship between GA and pSTAT3
response to IFNa in cytotoxic effector cells, specifically CD8+T
effector cells, including effector memory CD8+ T cells
(CD8+TEM), CD8
+ effector memory T cells re-expressing
CD45RA(CD8+TEMRA); CD8
+NKT-like cells; and two major
A B C D
E F G
H I
FIGURE 4 | Advancing GA is associated increasing frequency of key defensive innate immune cells and with decreasing frequency of invariant and regulatory
T cell subsets. (A) Community 3 contained 164 informative immune features (164 nodes), including frequencies innate and adaptive immune cell subsets.
(B–I) Relationship between GA and highlighted features in community 3. The frequency of granulocytes and cMCs increased with GA, while the frequency of
NKT-like cells, Treg cells, and CD161-expressing CD4
+ and CD8+ T cells decreased with GA. Spearman correlations.
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subsets of NK cells defined by CD16 and CD56 expression, i.e.
CD56dimCD16+ NK and CD56brightCD16- cells (Figures 6B–E,
G). CD8+ T central memory cells (CD8+TCM) showed a trend
that did not quite reach statistical significance after Benjamini-
Hochberg correction (FDR=0.11) (Figure 6F). The strong
inverse correlation of pSTAT3 activation with GA prompted
us to investigate pSTAT1 in the same cell types, given that
STAT1 is the classic downstream effector of IFNa.(46) In this
pathway, we identified a similar pattern, although less
pronounced (Supplemental Figure S4). The results are
consistent with known clinical observations of susceptibility of
preterm infants to viral infections, although the role of the non-
classical pSTAT3, which may have a regulatory function, may




FIGURE 6 | Cytotoxic cells exhibit increasing pSTAT3 response to IFNa with advancing GA. (A) Community 4b contains information on 67 immune features
corresponding to the response of the STAT pathway to IFNa. (B–G) Highlighted immune features in community 4b show increasing responsiveness of pSTAT-3 in




FIGURE 5 | Antigen presenting cell subsets exhibit decreasing basal MAP-kinase/NFkB pathway signaling with GA but increasing signaling responsiveness to LPS.
(A) Community 3 contains information on 123 immune features corresponding to the basal signaling of the MAP-kinase/NFkB pathway, and community 4c contains
information on 16 immune features corresponding to the response of the same pathway to LPS. (B–D) Highlighted immune features in community 3 show
decreasing basal pMAPKAPK2 signaling in antigen presenting cells. (E–G) Highlighted immune features in community 4c show increasing pMAPKAPK2 signaling in
response to LPS in the same cells. Spearman correlations.
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DISCUSSION
In this study, we employed mass cytometry and high-dimensional
analysis to provide a comprehensive characterization of the GA-
dependent progression of the neonatal immune system at birth
from infants ranging from extremely preterm to term. An
overarching motif was a progressive increase in the ligand-specific
responsiveness to stimulation of the immune system as illustrated
by a transition from a system characterized by low-amplitude
antigen (LPS)- and cytokine (IFNa, IL-2, IL-4, and IL-6)- specific
immune responses with high basal signaling tone to one more
capable of eliciting ligand-specific reactions to immunologic
challenges (Figures 3C and 7). This observation raises the
hypothesis that the elevated basal signaling tone of key mediators
of inflammation, including antigen presenting cells, may contribute
to the unique susceptibility of preterm infants to hyper-
inflammatory reactions to non-pathogenic stimulation, whereas
the decreased antigen- and cytokine-specific responses might
leave the preterm infant susceptible to infection.
Our analysis confirmed a strong relationship between GA and
the neonatal immune profile at birth (R=0.85, p=8.75e-14) and
revealed numerous GA-dependent immune adaptations, many
of which are completely novel while others align with existing
literature. Early GA is known to be associated with deficient
numbers of granulocytes and cMCs (26, 29, 48, 49); elevation of
Treg cells (50–52); elevation of NKT-like cells (53); and elevation
of CD161-expressing CD4+ T cells (39, 39, 54–56). Notably, our
findings on the relationship between GA and the frequency of
granulocytes align with those published by Olin et al. who used
similar mass cytometry techniques to study term and preterm
infants (29). In their study, which included mass cytometric
analysis of 21 cell types found in the cord blood of term patients
(defined as >37 weeks GA) and preterm patients (defined as <30
weeks GA), the frequency of granulocytes was the largest
contributor to variance between term and preterm samples,
which is corroborated in our data where granulocyte frequency
was the most frequently identified feature in our bootstrap
(R=0.77, p=8.5e-10). Each of these findings has the potential to
be clinically significant for the preterm infant. Decreased
numbers of cMCs and granulocytes contribute to the
susceptibility of premature infants to opportunistic infections
by extracellular pathogens such as Group B Streptococcus (GBS),
Escheria coli, and Candida albicans, which are the major causes
of sepsis in the preterm infant and are associated with 30%, 38%
(14), and 34% (57) mortality, respectively. In utero, TREGs
specific to maternal antigens likely inhibit the activation of
allo-reactive inflammatory fetal conventional a/b T cells,
which are implicated in preterm labor in humans (17, 58) and
have been shown to precipitate preterm labor in mice (59). While
this inhibition of antigen-specific responses is helpful during
fetal life, it may be detrimental in postnatal life when the infant is
required to mount targeted pro-inflammatory responses towards
FIGURE 7 | Summary schematic As GA advances, we observed an increase in ligand-specific immune signaling coupled with a decrease in non-specific basal
signaling (bottom). As a complement to this change in signaling patterns, we also described an inverse relationship between GA and the prevalence of suppressor-
type T cells (Treg cells and possibly CD161
+ CD4+ T cells), which have the potential to inhibit antigen-specific inflammation and prevalence of non-conventional
innate-like T cells such as NKT-like cells and CD8+CD161+ T cells (classically associated with MAIT cells) (top left). As GA advances the proportion of these inhibitory
and non-conventional T cells decreases, the responsiveness of both innate and adaptive cells to antigen (LPS) and cytokine (IFNa and IL-2, IL-4, and IL-6)
stimulation increases, and the population of quick-acting innate defender cells increases (top right).
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pathogens. Interestingly, disordered Treg cells are implicated in
the major inflammatory diseases of prematurity, including NEC
(60–63), BPD (64), and oxygen-induced retinopathy (such as
ROP) (65). NKT-like cells, which are also elevated at early GA,
are non-conventional innate-like T cells that express invariant
TCRs specific for lipid antigens (53, 66, 67). The clinical role of
CD161-expressing CD4+ and CD8+ T cells in the fetus and
neonate is less well studied. In adults, CD161 on CD4+ and CD8+
T cells is classically associated with TH17 (68) and mucosal
associated invariant T (MAIT) cells (69, 70), respectively, where
it likely acts as a stimulatory co-signal in the setting of TCR
engagement (66, 71–73). Although an area of ongoing
investigation, there is some evidence to suggest that
abnormally elevated TH17-type responses are associated with
NEC (60, 63). Of note, a recent study demonstrated that CD161
on human fetal CD4+ T cells acts as an inhibitory co-signal in a
fetal-specific manner (39). The role of CD161+CD8+ T cells in
the fetus and neonate is poorly understood, and to our
knowledge ours is the first study to show decreasing frequency
of CD161+CD8+ T cells with advancing GA. These cells are
similar to NKT-like cells in that they express invariant TCRs and
recognize non-peptide antigens, specifically riboflavin
metabolites presented by the non-classical MHC molecule
MR1 (41, 42). Similar to the role of Tregs, the emphasis on
non-conventional T cells (e.g. CD161+CD8+ T cells/MAIT-like
and NKT-like cells) early in gestation may be beneficial in
limiting the risk of an allogenic reaction of the fetus against its
mother, as these reactions are typically mediated by conventional
a/b T cells. A caveat to consider is that the decreasing frequency
of these unconventional T cell subsets in the peripheral
circulation with advancing GA may actually reflect migration
to the tissues. Nonetheless, a better understanding of the
function and dynamics of these unusual T cells has the
potential to provide insight into the unique immunobiology of
prematurity. Overall the premature neonatal immune cell
repertoire is characterized by underpopulated first line of
defense innate cells (granulocytes and cMCs), a higher
proportion of non-conventional innate-like T cells, and higher
numbers of T cells with a known or putative regulatory role.
In addition to changes in immune cell distribution, the
functional assessment of intracellular signaling activities
revealed novel adaptations of the neonatal immune system
with advancing GA. Consistent with prior findings, we found
that antigen presenting cells, including DCs and monocyte
subsets, in preterm neonates demonstrate decreased MAP-
kinase/NFkB signaling responsiveness to TLR-4 stimulation
with LPS (74–76). However, we also observed an inverse
relationship between GA and the basal signaling tone of the
MAP-kinase/NFkb pathways in the same cell types. The clinical
implications of this paradoxical finding are intriguing. On one
hand, a hypo-inflammatory response in the TLR-4 pathway is
consistent with vulnerability to infection, particularly by gram
negative bacteria. On the other hand, the elevated basal signaling
tone of this typically pro-inflammatory pathway could partly
explain the vulnerability of preterm infants to developing hyper-
inflammatory responses to environmental stimuli (e.g. oxygen,
mechanical ventilation, and commensal bacteria), which in turn
contribute to the inflammatory morbidities of prematurity.
Indeed, existing evidence implicates excessive MAP-kinase/
NFkb pathway activity in NEC (60, 77, 78), BPD (79–82), and
ROP (83, 84), although these studies have not provided
information on cell type specificity. One might speculate that
the exaggerated basal signaling in the NFkB pathway at early GA
could reflect a general feature of fetal tissues undergoing
proliferation, as NFkB signaling is anti-apoptotic (85). As such,
the MAP-kinase/NFkb pathway in inflammatory cells is a
promising target for future studies designed to understand the
vulnerability of premature infants to hyper-inflammation.
In parallel to the increasing responsiveness of antigen
presenting cells to bacterial antigens, we observed a similar
increase in responsiveness of cytotoxic lymphocytes to the
virus-associated type 1 interferon IFNa with advancing GA.
While basal signaling tone did not change with respect to GA
(data not shown), both pSTAT3 and pSTAT1 signaling response
to IFNa increased with GA in major cytotoxic lymphocyte
subsets: CD8+ T effector and memory cells; NK cells, including
CD56bright CD16- and CD56dimCD16+; and CD8+NKT-like cells.
Other authors have demonstrated that neonatal NK cells (86, 87)
and CD8+ T cells are less cytotoxic (88) than adult and shown
that this phenomenon is exaggerated in preterm vs term infants
(89). However, the mechanism for this deficiency is unknown. In
adults, IFNa primes cytotoxic cell types for optimum
cytotoxicity (90), and pSTAT1 (when dimerized with pSTAT2)
is the classic pro-inflammatory mediator of IFNa signaling (46).
As such, impairment of STAT signaling in response to IFNa in
prematurity might explain the poor cytotoxicity of these cell
types, and in turn the unique vulnerability of premature infants
to certain viral pathogens such as herpes simplex virus,
cytomegalovirus, and adenovirus. Interestingly, the association
of pSTAT1 signaling with GA was less strong than that of
pSTAT3. This STAT molecule’s role in IFNa signaling is less
well described, but it may act as a counter-regulatory molecule
that suppresses the inflammatory response to type 1 interferons
(47). Therefore, our evidence suggests a simultaneous imbalance
in both the pro-inflammatory and counter-regulatory response
to IFNa in cytotoxic cells in premature infants compared to
term infants.
Our study has several limitations. The preterm infants in our
cohort were born to mothers with a diverse range of comorbidities
and were delivered for a variety of different indications, inevitably
introducing clinical confounders (Supplemental Tables S2, S3).
Importantly, our model remains significant when themost clinically
plausible confounders are controlled for– specifically fetal sex,
preeclampsia, preeclampsia with severe features, duration of labor,
duration of rupture of membranes, group B streptococcus status,
maternal gestational diabetes, maternal hemoglobin A1c, and time
since administration of antenatal steroids. Notably, all infants in our
study born preterm (<37 weeks GA) were exposed to antenatal
steroids, whereas none of the term infants had been exposed.
Reassuringly, the time between steroid administration and birth
was not a significant confounder of our ENmodel, which provides a
statistical foundation to support the premise that steroids are not the
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main driver of our findings (Supplemental Table S4). Furthermore,
although antenatal steroid administration will inevitably impact the
immune system, it reflects clinical reality as approximately 77-88%
of preterm infants in the United States are born after maternal
steroid administration given to promote fetal lung maturity (91, 92).
Additionally, many of the intracellular immunologic features we
identified as variable with respect to GA are not known to be
directly affected by glucocorticoids, and some trends, such as
elevated MAP-kinase/NFkb baseline signaling, are counter to the
expected effect of glucocorticoids (93). It should also be noted that
umbilical cord blood provides a snapshot of the immune system at
the time of birth but may not reflect the post-natal immune profile
(29, 94). Nonetheless, several smaller studies have suggested that the
immune status at the time of birth correlates with the development
of later morbidity and mortality, so cord blood remains a clinically
relevant sample (21–24, 26). Lastly, while we measured proximal
signaling responses by assaying phosphorylation states of signaling
molecules, we do not have information on down-stream
functional changes.
In summary, we applied a high-dimensional immunoassay to
perform a single-cell analysis of neonatal immune cell
distribution and signaling responses at the time of birth along
the spectrum of viable gestational age, ranging from extremely
premature to term. Our findings revealed GA-dependent
adaptations in the balance between pro- and anti-inflammatory
immune mechanisms within both the adaptive and innate
compartments. We observed a progressive decrease in the
relative proportion of non-classical and suppressor T cell
subsets, a decrease in basal immune cell signaling tone, and an
increase in the ligand-specific responsiveness of the neonatal
immune system. The detailed knowledge gained from our study
provides an important framework to better understand, predict
and treat the unique set of infectious and inflammatory diseases
suffered by preterm infants.
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D, et al. Preterm Neonates Show Marked Leukopenia and Lymphopenia That
are Associated With Increased Regulatory T-Cell Values and Diminished
IL-7. Pediatr Res (2012) 71(5):590–7. doi: 10.1038/pr.2012.6
49. Ohls RK, Li Y, Abdel-Mageed A, Buchanan G, Mandell L, Christensen RD.
Neutrophil Pool Sizes and Granulocyte Colony-Stimulating Factor
Production in Human Mid-Trimester Fetuses. Pediatr Res (1995) 37
(6):806–11. doi: 10.1203/00006450-199506000-00022
50. Cupedo T, Nagasawa M, Weijer K, Blom B, Spits H. Development and
Activation of Regulatory T Cells in the Human Fetus. Eur J Immunol (2005)
35:383–90. doi: 10.1002/eji.200425763
51. Mold JE, Michaëlsson J, Burt TD, Muench MO, Beckerman KP, Busch MP,
et al. Maternal Alloantigens Promote the Development of Tolerogenic Fetal
Regulatory T Cells In Utero. Science (2008) 322(5907):1562–5. doi: 10.1126/
science.1164511
52. Darrasse-Jèze G, Darrasse-Jèze G, Klatzmann D, Charlotte F, Salomon BL,
Cohen JL. CD4+CD25+ Regulatory/Suppressor T Cells Prevent Allogeneic
Peterson et al. Neonatal Immune System Across GA
Frontiers in Immunology | www.frontiersin.org August 2021 | Volume 12 | Article 71409012
Fetus Rejection in Mice. Immunol Lett (2006) 102:106–9. doi: 10.1016/
j.imlet.2005.07.002
53. Ladd M, Sharma A, Huang Q, Wang AY, Xu L, Genowati I, et al. Natural
Killer T Cells Constitutively Expressing the Interleukin-2 Receptor a Chain
Early in Life are Primed to Respond to Lower Antigenic Stimulation.
Immunology (2010) 131(2):289–99. doi: 10.1111/j.1365-2567.2010.03304.x
54. Li N, van Unen V, Abdelaal T, Guo N, Kasatskaya SA, Ladell K, et al. Memory
CD4+ T Cells are Generated in the Human Fetal Intestine. Nat Immunol
(2019) 20(3):301–12. doi: 10.1038/s41590-018-0294-9
55. Rackaityte E, Halkias J, Fukui EM, Mendoza VF, Hayzelden C, Crawford ED,
et al. Viable Bacterial Colonization Is Highly Limited in the Human Intestine
In Utero. Nat Med (2020) 26(4):599–607. doi: 10.1038/s41591-020-0761-3
56. Ben Youssef G, Tourret M, Salou M, Ghazarian L, Houdouin V, Mondot S,
et al. Ontogeny of Human Mucosal-Associated Invariant T Cells and Related
T Cell Subsets. J Exp Med (2018) 215(2):459–79. doi: 10.1084/jem.20171739
57. Benjamin DK, Stoll BJ, Gantz MG, Walsh MC, Sanchez PJ, Das A, et al.
Neonatal Candidiasis: Epidemiology, Risk Factors, and Clinical Judgment.
Pediatrics (2010) 126(4):e865–73. doi: 10.1542/peds.2009-3412
58. Frascoli M, Coniglio L, Witt R, Jeanty C, Fleck-Derderian S, Myers DE, et al.
Alloreactive Fetal T Cells Promote Uterine Contractility in Preterm Labor via
IFN-g and TNF-a. Sci Transl Med (2018) 10(438):eaan2263. doi: 10.1126/
scitranslmed.aan2263
59. Gomez-Lopez N, Romero R, Xu Y, Miller D, Arenas-Hernandez M, Garcia-
Flores V, et al. Fetal T Cell Activation in the Amniotic Cavity During Preterm
Labor: A Potential Mechanism for a Subset of Idiopathic Preterm Birth.
J Immunol (2019) 203(7):1793–807. doi: 10.4049/jimmunol.1900621
60. Egan CE, Sodhi CP, Good M, Lin J, Jia H, Yamaguchi Y, et al. Toll-Like
Receptor 4–Mediated Lymphocyte Influx Induces Neonatal Necrotizing
Enterocolitis. J Clin Invest 126(2):495–508. doi: 10.1172/JCI83356
61. Liu Y, Tran DQ, Fatheree NY, Marc Rhoads J. Lactobacillus Reuteri DSM
17938 Differentially Modulates Effector Memory T Cells and Foxp3+
Regulatory T Cells in a Mouse Model of Necrotizing Enterocolitis. Am J
Physiol Gastrointest Liver Physiol (2014) 307:G177–86. doi: 10.1152/
ajpgi.00038.2014
62. Weitkamp J-H, Koyama T, Rock MT, Correa H, Goettel JA, Matta P, et al.
Necrotising Enterocolitis is Characterised by Disrupted Immune Regulation
and Diminished Mucosal Regulatory (FOXP3)/effector (CD4, CD8) T Cell
Ratios. Gut (2013) 62(1):73–82. doi: 10.1136/gutjnl-2011-301551
63. Ma F, Li S, Gao X, Zhou J, Zhu X, Wang D, et al. Interleukin-6-Mediated
CCR9+ Interleukin-17-Producing Regulatory T Cells Polarization Increases
the Severity of Necrotizing Enterocolitis. EBioMedicine (2019) 44:71–85. doi:
10.1016/j.ebiom.2019.05.042
64. Misra R, Shah S, Fowell D, Wang H, Scheible K, Misra S, et al. Preterm Cord
Blood CD4+ T Cells Exhibit Increased IL-6 Production in Chorioamnionitis
and Decreased CD4+ T Cells in Bronchopulmonary Dysplasia.Hum Immunol
(2015) 76(5):329–38. doi: 10.1016/j.humimm.2015.03.007
65. Deliyanti D, Talia DM, Zhu T, Maxwell MJ, Agrotis A, Jerome JR, et al. Foxp3 +
Tregs are Recruited to the Retina to Repair Pathological Angiogenesis. Nat
Commun (2017) 8(1):748. doi: 10.1038/s41467-017-00751-w
66. Exley M, Porcelli S, Furman M, Garcia J, Balk S. CD161 (NKR-P1A)
Costimulation of CD1d-Dependent Activation of Human T Cells
Expressing Invariant Va24jaq T Cell Receptor a Chains. J Exp Med (1998)
188:867–76. doi: 10.1084/jem.188.5.867
67. Brennan PJ, Brigl M, Brenner MB. Invariant Natural Killer T Cells: An Innate
Activation Scheme Linked to Diverse Effector Functions. Nat Rev Immunol
(2013) 13:101–17. doi: 10.1038/nri3369
68. Cosmi L, De Palma R, Santarlasci V, Maggi L, Capone M, Frosali F, et al.
Human Interleukin 17-Producing Cells Originate From a CD161+CD4+ T
Cell Precursor. J Exp Med (2008) 205(8):1903–16. doi: 10.1084/jem.20080397
69. Billerbeck E, Kang Y-H, Walker L, Lockstone H, Grafmueller S, Fleming V,
et al. Analysis of CD161 Expression on Human CD8+ T Cells Defines a
Distinct Functional Subset With Tissue-Homing Properties. Proc Natl Acad
Sci (2010) 107(7):3006–11. doi: 10.1073/pnas.0914839107
70. Bourhis LL, Dusseaux M, Bohineust A, Bessoles S, Martin E, Premel V, et al.
MAIT Cells Detect and Efficiently Lyse Bacterially-Infected Epithelial Cells.
PloS Pathog (2013) 9(10):e1003681. doi: 10.1371/journal.ppat.1003681
71. Fergusson JR, Smith KE, Fleming VM, Rajoriya N, Newell EW, Simmons R,
et al. CD161 Defines a Transcriptional and Functional Phenotype Across
Distinct Human T Cell Lineages. Cell Rep (2014) 9(3):1075–88. doi: 10.1016/
j.celrep.2014.09.045
72. Germain C, Meier A, Jensen T, Knapnougel P, Poupon G, Lazzari A, et al.
Induction of Lectin-Like Transcript 1 (LLT1) Protein Cell Surface Expression
by Pathogens and Interferon-g Contributes to Modulate Immune Responses.
J Biol Chem (2011) 286(44):37964–75. doi: 10.1074/jbc.M111.285312
73. Aldemir H, Prod’homme V, Dumaurier M-J, Retiere C, Poupon G, Cazareth J,
et al. Cutting Edge: Lectin-Like Transcript 1 Is a Ligand for the CD161 Receptor.
J Immunol (2005) 175(12):7791–5. doi: 10.4049/jimmunol.175.12.7791
74. Förster-Waldl E, Sadeghi K, Tamandl D, Gerhold B, Hallwirth U, Rohrmeister
K, et al. Monocyte Toll-Like Receptor 4 Expression and LPS-Induced
Cytokine Production Increase During Gestational Aging. Pediatr Res (2005)
58(1):121–4. doi: 10.1203/01.PDR.0000163397.53466.0F
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